Acadia Pharmaceuticals (ACAD) Income from Continuing Operations (2010 - 2026)
Acadia Pharmaceuticals (ACAD) recorded Income from Continuing Operations of $31.5 million in Q2 2026, up 18.1% from $26.67 million a year earlier and up 761.6% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Income from Continuing Operations (2010 - 2026) Analysis & Trends
On a TTM basis, Acadia Pharmaceuticals' Income from Continuing Operations came in at $380.51 million as of Jun 30, 2026, up 71.3% year-over-year; for FY2025, it was $391 million, up 72.7% from FY2024.
- Across earlier years, Income from Continuing Operations came in at $226.45 million in FY2024, -$61.29 million in FY2023, -$215.98 million in FY2022 and -$167.87 million in FY2021.
- Quarterly Income from Continuing Operations has ranged from -$113.1 million in Q1 2022 to $273.55 million in Q4 2025 over the past five years.
- On a year-over-year basis, Income from Continuing Operations rose in five of the last seven quarters, with growth averaging 50.8%.
- Per Business Quant, the preceding three quarters came in at $3.66 million (Q1 2026), $273.55 million (Q4 2025) and $71.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Acadia Pharmaceuticals | 3.47 Bn | -4.91 Mn | 279.64 Mn | 31.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.50 Mn |
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | 273.55 Mn |
| Sep 30, 2025 | 71.80 Mn |
| Jun 30, 2025 | 26.67 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | 143.75 Mn |
| Sep 30, 2024 | 32.77 Mn |
| Jun 30, 2024 | 33.40 Mn |
| Mar 31, 2024 | 16.56 Mn |
| Dec 31, 2023 | 45.80 Mn |
| Sep 30, 2023 | -65.18 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | -43.02 Mn |
| Dec 31, 2022 | -41.68 Mn |
| Sep 30, 2022 | -27.22 Mn |
| Jun 30, 2022 | -34.04 Mn |
| Mar 31, 2022 | -113.10 Mn |
| Dec 31, 2021 | -43.09 Mn |
| Sep 30, 2021 | -14.46 Mn |
API Access
Acadia Pharmaceuticals Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();